Følg
Toby Michael Maher
Toby Michael Maher
Keck Medicine of University of Southern California
Verificeret mail på rbht.nhs.uk - Startside
Titel
Citeret af
Citeret af
År
Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis
L Richeldi, RM Du Bois, G Raghu, A Azuma, KK Brown, U Costabel, ...
New England Journal of Medicine 370 (22), 2071-2082, 2014
42742014
Nintedanib for systemic sclerosis–associated interstitial lung disease
O Distler, KB Highland, M Gahlemann, A Azuma, A Fischer, MD Mayes, ...
New England Journal of Medicine 380 (26), 2518-2528, 2019
12832019
Interstitial lung disease in systemic sclerosis: a simple staging system
NSL Goh, SR Desai, S Veeraraghavan, DM Hansell, SJ Copley, ...
American journal of respiratory and critical care medicine 177 (11), 1248-1254, 2008
12122008
Acute exacerbation of idiopathic pulmonary fibrosis. An international working group report
HR Collard, CJ Ryerson, TJ Corte, G Jenkins, Y Kondoh, DJ Lederer, ...
American journal of respiratory and critical care medicine 194 (3), 265-275, 2016
12102016
Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an official ATS/ERS/JRS/ALAT clinical practice guideline
G Raghu, M Remy-Jardin, L Richeldi, CC Thomson, Y Inoue, T Johkoh, ...
American Journal of Respiratory and Critical Care Medicine 205 (9), e18-e47, 2022
9542022
Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis
TE Fingerlin, E Murphy, W Zhang, AL Peljto, KK Brown, MP Steele, ...
Nature genetics 45 (6), 613-620, 2013
7852013
Pulmonary fibrosis secondary to COVID-19: a call to arms?
P Spagnolo, E Balestro, S Aliberti, E Cocconcelli, D Biondini, ...
The Lancet Respiratory Medicine 8 (8), 750-752, 2020
5582020
The role of bacteria in the pathogenesis and progression of idiopathic pulmonary fibrosis
PL Molyneaux, MJ Cox, SAG Willis-Owen, P Mallia, KE Russell, ...
American journal of respiratory and critical care medicine 190 (8), 906-913, 2014
5062014
Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial
TM Maher, TJ Corte, A Fischer, M Kreuter, DJ Lederer, M Molina-Molina, ...
The lancet Respiratory medicine 8 (2), 147-157, 2020
5022020
Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised …
AU Wells, KR Flaherty, KK Brown, Y Inoue, A Devaraj, L Richeldi, T Moua, ...
The lancet Respiratory medicine 8 (5), 453-460, 2020
4202020
Idiopathic pulmonary fibrosis: multiple causes and multiple mechanisms?
TM Maher, AU Wells, GJ Laurent
European Respiratory Journal 30 (5), 835-839, 2007
4132007
Pleuroparenchymal fibroelastosis: a spectrum of histopathological and imaging phenotypes
TL Reddy, M Tominaga, DM Hansell, J von der Thusen, D Rassl, ...
European Respiratory Journal 40 (2), 377-385, 2012
3772012
Increased local expression of coagulation factor X contributes to the fibrotic response in human and murine lung injury
CJ Scotton, MA Krupiczojc, M Königshoff, PF Mercer, YCG Lee, ...
The Journal of clinical investigation 119 (9), 2550-2563, 2009
3752009
Short‐term pulmonary function trends are predictive of mortality in interstitial lung disease associated with systemic sclerosis
NS Goh, RK Hoyles, CP Denton, DM Hansell, EA Renzoni, TM Maher, ...
Arthritis & rheumatology 69 (8), 1670-1678, 2017
3022017
Longitudinal change in collagen degradation biomarkers in idiopathic pulmonary fibrosis: an analysis from the prospective, multicentre PROFILE study
RG Jenkins, JK Simpson, G Saini, JH Bentley, AM Russell, R Braybrooke, ...
The lancet Respiratory medicine 3 (6), 462-472, 2015
3012015
Rituximab in severe, treatment‐refractory interstitial lung disease
GJ Keir, TM Maher, D Ming, R Abdullah, A de Lauretis, ...
Respirology 19 (3), 353-359, 2014
2872014
Pulmonary macrophages: a new therapeutic pathway in fibrosing lung disease?
AJ Byrne, TM Maher, CM Lloyd
Trends in molecular medicine 22 (4), 303-316, 2016
2842016
Serum interleukin 6 is predictive of early functional decline and mortality in interstitial lung disease associated with systemic sclerosis
A De Lauretis, P Sestini, P Pantelidis, R Hoyles, DM Hansell, NSL Goh, ...
The Journal of rheumatology 40 (4), 435-446, 2013
2762013
Genetic variants associated with susceptibility to idiopathic pulmonary fibrosis in people of European ancestry: a genome-wide association study
RJ Allen, J Porte, R Braybrooke, C Flores, TE Fingerlin, JM Oldham, ...
The Lancet respiratory medicine 5 (11), 869-880, 2017
2612017
Idiopathic pulmonary fibrosis: Disease mechanisms and drug development
P Spagnolo, JA Kropski, MG Jones, JS Lee, G Rossi, T Karampitsakos, ...
Pharmacology & therapeutics 222, 107798, 2021
2582021
Systemet kan ikke foretage handlingen nu. Prøv igen senere.
Artikler 1–20